Perth-based cannabis trial hits exciting milestone

by Newsfeed


After two years of hard work and multiple hurdles to overcome, The University of Notre Dame Australia’s Institute for Health Research (IHR) and MGC Pharma have hit a new milestone with publication of the study protocol for the clinical trial on the value of medical cannabis for patients with dementia.

This trial has been registered in the Australian and New Zealand Clinical Trial Register and, following rigorous review by external experts of the study’s design and planned analytical methods, its protocol has just been published in the prestigious journal, Trial. The study is currently the only one in Australia into the potential benefits of medical cannabis in Dementia patients.

Recruitment into the study has been challenging as the Western Australian Guardianship and Administration Act (1990), unlike in the…



Read Full Article Here

save 80% off #1 trusted top selling CBD and Hemp P

You may also like